NO20003131L - Krystallinsk teriparatid - Google Patents

Krystallinsk teriparatid

Info

Publication number
NO20003131L
NO20003131L NO20003131A NO20003131A NO20003131L NO 20003131 L NO20003131 L NO 20003131L NO 20003131 A NO20003131 A NO 20003131A NO 20003131 A NO20003131 A NO 20003131A NO 20003131 L NO20003131 L NO 20003131L
Authority
NO
Norway
Prior art keywords
teriparatide
crystalline
purification
pure
preparation
Prior art date
Application number
NO20003131A
Other languages
English (en)
Other versions
NO20003131D0 (no
Inventor
Faming Zhang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20003131L publication Critical patent/NO20003131L/no
Publication of NO20003131D0 publication Critical patent/NO20003131D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)

Abstract

Rene, stabile krystallinske former av parathyroidhormon, særlig teriparatid, er beskrevet så vel som fremgangsmåter for fremstilling og rensing.
NO20003131A 1997-12-18 2000-06-16 Krystallinsk teriparatid NO20003131D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6987597P 1997-12-18 1997-12-18
PCT/US1998/026044 WO1999031137A1 (en) 1997-12-18 1998-12-08 Crystalline teriparatide

Publications (2)

Publication Number Publication Date
NO20003131L true NO20003131L (no) 2000-06-16
NO20003131D0 NO20003131D0 (no) 2000-06-16

Family

ID=22091750

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003131A NO20003131D0 (no) 1997-12-18 2000-06-16 Krystallinsk teriparatid

Country Status (24)

Country Link
US (1) US6590081B1 (no)
EP (1) EP0926158B1 (no)
JP (1) JP2002508395A (no)
KR (1) KR20010033268A (no)
CN (1) CN1281467A (no)
AR (1) AR038648A1 (no)
AT (1) ATE245165T1 (no)
AU (1) AU748271B2 (no)
BR (1) BR9813740A (no)
CA (1) CA2315103A1 (no)
DE (1) DE69816409T2 (no)
DK (1) DK0926158T3 (no)
EA (1) EA200000672A1 (no)
ES (1) ES2202729T3 (no)
HU (1) HUP0100075A2 (no)
ID (1) ID25660A (no)
IL (1) IL136824A0 (no)
NO (1) NO20003131D0 (no)
PE (1) PE20000056A1 (no)
PL (1) PL341209A1 (no)
PT (1) PT926158E (no)
TR (1) TR200002179T2 (no)
WO (1) WO1999031137A1 (no)
ZA (1) ZA9811407B (no)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601685B2 (en) 1998-08-27 2009-10-13 Eidgenossische Technische Hochschule Zurich Growth factor modified protein matrices for tissue engineering
EP1864681A1 (en) 2001-12-18 2007-12-12 Eidgenössische Technische Hochschule Zürich Growth factor modified protein matrices for tissue engineering
JP4560291B2 (ja) * 2001-12-18 2010-10-13 イジュノシッヒ テクニッヒ ホッフシューラ チューリッヒ 組織操作のための成長因子改変タンパク質マトリクス
US7247609B2 (en) 2001-12-18 2007-07-24 Universitat Zurich Growth factor modified protein matrices for tissue engineering
WO2004022033A1 (en) * 2002-09-04 2004-03-18 Microchips, Inc. Method and device for the controlled delivery of parathyroid hormone
DK1581251T3 (da) 2002-12-31 2016-06-27 Althea Tech Inc Krystaller af humant væksthormon og fremgangsmåder til fremstilling deraf
US8088734B2 (en) 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
US7429378B2 (en) * 2003-05-13 2008-09-30 Depuy Spine, Inc. Transdiscal administration of high affinity anti-MMP inhibitors
US7553827B2 (en) * 2003-08-13 2009-06-30 Depuy Spine, Inc. Transdiscal administration of cycline compounds
US8273347B2 (en) * 2003-05-13 2012-09-25 Depuy Spine, Inc. Autologous treatment of degenerated disc with cells
US20040229878A1 (en) * 2003-05-13 2004-11-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of P38 kinase
US7344716B2 (en) * 2003-05-13 2008-03-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
US8361467B2 (en) * 2003-07-30 2013-01-29 Depuy Spine, Inc. Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
US8895540B2 (en) * 2003-11-26 2014-11-25 DePuy Synthes Products, LLC Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
US20060127320A1 (en) * 2004-05-10 2006-06-15 Nastech Pharmaceutical Company Inc. Method of delivering parathyroid hormone to a human
US20060052305A1 (en) * 2004-05-10 2006-03-09 Nastech Pharmaceutical Company Inc. Method of treating osteoporosis using intranasal parathyroid hormone
RU2006143544A (ru) * 2004-05-10 2008-06-20 Нэстек Фармасьютикал Кампани Инк. (Us) Композиции и способ для облегченной чресслизистой доставки паратиреоидного гормона
AU2005244734A1 (en) 2004-05-13 2005-12-01 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
WO2006073711A2 (en) 2005-01-06 2006-07-13 Kuros Biosurgery Ag Use of a matrix comprising a contrast agent in soft tissues
US8575101B2 (en) 2005-01-06 2013-11-05 Kuros Biosurgery Ag Supplemented matrices for the repair of bone fractures
EP1843783B1 (en) 2005-01-25 2012-05-30 MicroCHIPS, Inc. Control of drug release by transient modification of local microenvironments
US7691105B2 (en) 2005-09-26 2010-04-06 Depuy Spine, Inc. Tissue augmentation, stabilization and regeneration technique
US20070088436A1 (en) * 2005-09-29 2007-04-19 Matthew Parsons Methods and devices for stenting or tamping a fractured vertebral body
US20070173447A1 (en) * 2005-10-25 2007-07-26 Nastech Pharmaceutical Company Inc. Method for treating osteoporosis by intranasal delivery of teriparatide with an anti-resorptive agent
CN101355959B (zh) * 2005-11-10 2013-02-27 密歇根理工大学管理委员会 黑熊甲状旁腺素和使用黑熊甲状旁腺素的方法
US20080051332A1 (en) * 2005-11-18 2008-02-28 Nastech Pharmaceutical Company Inc. Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone
US20070168041A1 (en) * 2006-01-17 2007-07-19 Sudhakar Kadiyala Method and instruments for intervertebral disc augmentation through a pedicular approach
PL2136850T3 (pl) 2007-04-13 2012-07-31 Kuros Biosurgery Ag Polimeryczny uszczelniacz tkankowy
BRPI0721943A2 (pt) * 2007-08-09 2014-03-18 Usv Ltd Processo ortogonal para purificação do hormônio da paratireoide humano recombinante (rhpth) (1-34)
US8741329B2 (en) * 2007-09-21 2014-06-03 Merck Sharp & Dohme B.V. Drug delivery system
US8241363B2 (en) 2007-12-19 2012-08-14 Depuy Spine, Inc. Expandable corpectomy spinal fusion cage
US8241294B2 (en) 2007-12-19 2012-08-14 Depuy Spine, Inc. Instruments for expandable corpectomy spinal fusion cage
US20090162351A1 (en) * 2007-12-21 2009-06-25 Depuy Spine, Inc. Transdiscal administration of inhibitors of p38 MAP kinase
US8986696B2 (en) * 2007-12-21 2015-03-24 Depuy Mitek, Inc. Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
WO2009083544A2 (en) 2007-12-28 2009-07-09 Kuros Biosurgery Ag Pdgf fusion proteins incorporated into fibrin foams
US8876905B2 (en) 2009-04-29 2014-11-04 DePuy Synthes Products, LLC Minimally invasive corpectomy cage and instrument
CA2782640A1 (en) 2009-12-07 2011-06-16 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
US8865220B2 (en) 2010-06-14 2014-10-21 Kaohsiung Medical University Method for controlled release of parathyroid hormone from encapsulated poly(lactic-glycolic)acid microspheres
WO2012123028A1 (en) 2011-03-16 2012-09-20 Kuros Biosurgery Ag Pharmaceutical formulation for use in spinal fusion
CN102731643A (zh) * 2012-06-26 2012-10-17 深圳翰宇药业股份有限公司 一种治疗骨质疏松多肽的制备方法
EP3079659B1 (en) 2013-12-11 2020-10-28 Merck Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
CN104910269B (zh) * 2015-06-02 2018-08-17 成都圣诺生物科技股份有限公司 一种合成特立帕肽的方法
JP6577683B2 (ja) * 2017-09-22 2019-09-18 旭化成ファーマ株式会社 安定性に優れるテリパラチド含有液状医薬組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62106000A (ja) 1985-10-30 1987-05-16 Fujitsu Ltd 生体高分子結晶自動作製装置
EP0415924B1 (en) * 1987-10-20 1996-05-29 HOLICK, Michael F Regulation of cell proliferation and differentiation using peptides
CA2120744A1 (en) 1991-10-09 1993-04-15 David J. Kenyon Crystal forming device and automated crystallization system
US5400741A (en) * 1993-05-21 1995-03-28 Medical Foundation Of Buffalo, Inc. Device for growing crystals
US5496801A (en) * 1993-12-23 1996-03-05 Allelix Biopharmaceuticals Inc. Parathyroid hormone formulation
US5419278A (en) * 1994-05-25 1995-05-30 Carter; Daniel C. Vapor equilibration tray for growing protein crystals
CA2178894A1 (en) * 1995-06-15 1996-12-16 Tsunehiko Fukuda Parathyroid hormone derivatives and their use

Also Published As

Publication number Publication date
ES2202729T3 (es) 2004-04-01
EP0926158A1 (en) 1999-06-30
PL341209A1 (en) 2001-03-26
BR9813740A (pt) 2000-10-10
AU1632699A (en) 1999-07-05
KR20010033268A (ko) 2001-04-25
TR200002179T2 (tr) 2001-07-23
US6590081B1 (en) 2003-07-08
DK0926158T3 (da) 2003-11-10
DE69816409T2 (de) 2004-06-09
PT926158E (pt) 2003-11-28
EA200000672A1 (ru) 2000-12-25
IL136824A0 (en) 2001-06-14
WO1999031137A1 (en) 1999-06-24
PE20000056A1 (es) 2000-02-08
HUP0100075A2 (hu) 2001-05-28
ID25660A (id) 2000-10-19
ATE245165T1 (de) 2003-08-15
JP2002508395A (ja) 2002-03-19
NO20003131D0 (no) 2000-06-16
ZA9811407B (en) 2000-07-13
DE69816409D1 (de) 2003-08-21
CA2315103A1 (en) 1999-06-24
EP0926158B1 (en) 2003-07-16
AR038648A1 (es) 2005-01-26
CN1281467A (zh) 2001-01-24
AU748271B2 (en) 2002-05-30

Similar Documents

Publication Publication Date Title
NO20003131L (no) Krystallinsk teriparatid
DK0813525T3 (da) Benzamidinderivater, deres fremstilling og anvendelse som antikoagulanter
NO20030374L (no) Syklopentanoindoler, preparater som inneholder slike forbindelser og behandlingsfremgangsmåter
DK0876332T3 (da) Phenyleddikesyrederivater, fremgangsmåde og mellemprodukter til deres fremstilling og midler indeholdende disse
DK1017670T3 (da) Benzamidoximderivater, mellemprodukter og fremgangsmåder til deres fremstilling og deres anvendelse som fungicider
FI934622A7 (fi) Menetelmä amylaasin puhdistamiseksi, näin saatu puhdistettu amylaasi ja puhdistetun amylaasin käytöt
DK0767798T3 (da) Sterolderivater anvendt til regulering af meiose
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
DK1040108T3 (da) Orthoanthranilamidderivater som antikoagulanter
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
DK1140018T3 (da) Polyol/olie-suspensioner til vedvarende frigørelse af proteiner
DK27087D0 (da) Genoprettelse af tilretning, dvs. framing i et kommunikationssystem
ES2158034T3 (es) Derivado de benzotiepina opticamente activo, su preparacion y uso.
DK1154986T3 (da) Fremgangsmåde til fremstilling af iopamidol
ATE202483T1 (de) Immuntolerante prothrombinkomplex-präparation
ECSP044973A (es) Nuevas formas polimorficas cristalinas de clorhidrato de lercanidipina y proceso para su preparacion
ES2195483T3 (es) Concentrado acuoso para suspension, que contiene tidiazuron y etefon.
DK1303267T3 (da) System til dermal tilförsel af aminolevulinsyre
ES2014546A6 (es) Procedimiento para la obtencion de fctor activador de neutrofilos.
DK0923599T3 (da) Fremgangsmåde til fremstilling af 17-estere af 9alfa, 21-dihalogenpregnan-11beta, 17alfa-diol-20-oner
NO990914L (no) Amorfe benzotiofener, fremgangsmÕter for fremstilling og fremgangsmÕter for anvendelse
NZ503372A (en) Chemical supplementation of bone by exposing bone to a therapeutic compound and applying a potential difference across the bone or tissue
FI945164A0 (fi) Biologisesti aktiivisesti ureidojohdannaiset, jotka ovat käyttökelpoisia antimetastaattisina aineina
DK1068209T3 (da) Fremgangsmåde til fremstilling af purinderivater og deres mellemprodukter
MX9202486A (es) Metodo para regular las actividades enzimaticas por gases nobles.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application